Research on the Construction of a Private Domain Full-Life Cycle Operation Platform for Automotive Brands
International Journal of World Economic Research · 2026
DOI: 10.54097/ezbb1474 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of World Economic Research, 2026. Verfasst von Dawei Xue und 1 weiteren Autor:innen. Die Arbeit nennt 6 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
This paper presents an integrated private domain operation platform designed for new energy vehicle manufacturers, covering four core modules: potential customer acquisition, marketing outreach, refined operations and maintenance, and data review. The platform integrates automotive-specific features such as social media traffic generation, referral-based viral growth, AI-powered automated marketing, and multi-dimensional user tagging and profiling. By connecting diverse customer acquisition channels, it enables tiered user management and a closed-loop operational cycle. The platform effectively accumulates brand-owned user assets, reduces customer acquisition costs, and improves conversion efficiency, providing a practical technical framework and theoretical foundation for automakers' private domain development and dealer performance evaluation.
Zitieren
APA
Xue, D., & Zang, H. (2026). Research on the Construction of a Private Domain Full-Life Cycle Operation Platform for Automotive Brands. International Journal of World Economic Research. https://doi.org/10.54097/ezbb1474
Vancouver
Xue D, Zang H. Research on the Construction of a Private Domain Full-Life Cycle Operation Platform for Automotive Brands. International Journal of World Economic Research. 2026. doi:10.54097/ezbb1474
BibTeX
@article{Xue2026,
author = {Xue, Dawei and Zang, Hao},
title = {Research on the Construction of a Private Domain Full-Life Cycle Operation Platform for Automotive Brands},
journal = {International Journal of World Economic Research},
year = {2026},
doi = {10.54097/ezbb1474}
}
EUVIMED